Albert David Limited (BOM:524075)
India · Delayed Price · Currency is INR 858.35
-9.15 (-1.05%)
At close: Sep 4, 2026
Albert David Market Cap
Albert David has a market cap or net worth of 4.9 billion as of September 4, 2026. Its market cap has increased by 7.09% in one year.
Market Cap
4.90B
Enterprise Value
2.62B
Revenue
3.64B
Ranking
n/a
PE Ratio
21.71
Stock Price
858.35
ChartMarket Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 4.90B, an increase of 5,987.59%. That is a compound annual growth rate of 17.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 4.90B | 15.99% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anuh Pharma | 8.14B |
| ZIM Laboratories | 6.72B |
| Kilitch Drugs (India) | 6.30B |
| Jenburkt Pharmaceuticals | 4.57B |
| Trident Lifeline | 3.50B |
| Medicamen Biotech | 3.44B |
| Ambalal Sarabhai Enterprises | 3.35B |
| Medico Remedies | 3.30B |